Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.
Source: xStation
IBM and Groq join forces to revolutionize AI processing
US Defense Industry Preview - Has it reached its peak?
Waymo: Race against the regulators
Will Alibaba’s Aegaeon Revolutionize GPU Usage?